Cheri Walker
Presidente presso Firefly BioWorks, Inc.
Profilo
Cheri Walker has held positions as President & Director at Firefly BioWorks, Inc. and Director at Brickbio, Inc.
Posizioni attive di Cheri Walker
| Società | Posizione | Inizio |
|---|---|---|
Brickbio, Inc.
 Brickbio, Inc. Packaged SoftwareTechnology Services Brickbio, Inc. operates as a bioconjugation platform for site-specific, site-selective modification of antibodies and other proteins. The company was founded by John Boyce and James Italia and is headquartered in Woburn, MA. | Direttore/Membro del Consiglio | - |
Firefly BioWorks, Inc.
 Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | Presidente | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Brickbio, Inc.
Brickbio, Inc. Packaged SoftwareTechnology Services Brickbio, Inc. operates as a bioconjugation platform for site-specific, site-selective modification of antibodies and other proteins. The company was founded by John Boyce and James Italia and is headquartered in Woburn, MA. | Technology Services |
Firefly BioWorks, Inc.
Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Cheri Walker
